Phase 1b/2 Study of Chitosan for Pharmacologic Manipulation of AGE (Advanced Glycation Endproducts) Levels in Prostate Cancer Patients

Unknown Phase 1,Phase 2 NCT03712371

Study Description

This study will examine the utility of chitosan for reduction of blood or tissue levels of AGEs in patients with prostate cancer who are clinically stable on androgen-deprivation therapy.

Study Details

Registry ID:: NCT03712371
Conditions:: Prostate Cancer
Phase:: Phase 1,Phase 2
Target Enrollment:: 12 participants
Start Date:: January 16, 2019
Healthy Volunteers:: No

Study Locations (1 site)

Medical University of South Carolina
Charleston, South CarolinaUnited States, United States

Interested in Participating?

Check your eligibility and learn more about this study on TrialScreen.

View full study details and check eligibility →